Funding Atlas programme
Call for Validation of biomarker candidates 2027
KWF Dutch Cancer Society (KWF Kankerbestrijding)
JurisdictionNetherlandsFunding typeGrant
Documented facts
Key facts
- Funder
- KWF Dutch Cancer Society (KWF Kankerbestrijding)
- Jurisdiction
- Netherlands
- Record type
- Opportunity
- Funding type
- Grant
- Amount
- 800,000 to 2,000,000
- Last deadline
- Closed 20 October 2026
Published rule provenance
Eligibility information
- Country / jurisdiction
Encoded condition recorded; read its source quotation.
Eligibility rule, quoted from the funder
The project leader must therefore be employed by a Dutch organisation for the duration of the project.
Quoted source- Organisation type
Rule not encoded
- Company size
Rule not encoded
- Stage
Rule not encoded
- Therapeutic area
Rule not encoded
- Amount sought
Rule not encoded
Further quoted conditions
Eligibility rule, quoted from the funder: trl
To clinically validate (combinations of) already known biomarkers that align with patient relevant outcomes or treatment responses and that can be used in daily clinical practice in the near future ( TRL5/6 ).Quoted source
Site note: This record is not advice or a funder decision.